Alpha Teknova initiated with a Sector Weight at KeyBanc

KeyBanc initiated coverage of Alpha Teknova with a Sector Weight rating and no price target. Alpha is a pure play on the reagents and consumables needed in a lab for cell therapy production, synthetic biology, and other processes, the analyst tells investors in a research note. The analyst views the company’s low-single-digit growth near-term and a capital raise as overhang for the shares.